Pyrosequencing for MYD88 L265P Mutation Discriminates between Lymphoplasmacytic Lymphoma and Marginal Zone Lymphoma

被引：0
|
作者：
Insuasti-Beltran, G.
Wenceslao, S.
Kang, H.
Gale, J. M.
Czuchlewski, D. R.
机构：
[1] Univ New Mexico, Albuquerque, NM 87131 USA
[2] TriCore Reference Labs, Albuquerque, NM USA
来源：
MODERN PATHOLOGY | 2013年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1401
引用
收藏
页码：334A / 334A
页数：1
相关论文
共 50 条
  • [41] Lasalocid A selectively induces the degradation of MYD88 in lymphomas harboring the MYD88 L265P mutation
    Li, Wei
    Wang, Ruirui
    Wang, Junhao
    Chai, Dafei
    Xie, Xiaohui
    Young, Ken H.
    Cao, Ya
    Li, Yong
    Yu, Xinfang
    BLOOD, 2025, 145 (10) : 1047 - 1060
  • [42] Therapy for MYD88 L265P DLBCL
    Vermaat, Joost S. P.
    de Groen, Ruben A. L.
    BLOOD, 2025, 145 (10) : 998 - 1000
  • [43] Investigating the frequency of somatic MYD88 L265P mutation in primary ocular adnexal B cell lymphoma
    Saraswathi, Karuvel Kannan
    Santhi, Radhakrishnan
    Kim, Usha
    Vanniarajan, Ayyasamy
    MOLECULAR BIOLOGY REPORTS, 2024, 51 (01)
  • [44] MYD88 L265P Mutation: A Valid Tool for Differential Diagnosis of Indolent Lymphoma With Overlapping Clinicopathologic Features?
    Preukschas, Michael
    Lebherz, Marina
    Hallas, Cora
    Tiemann, Markus
    LABORATORY INVESTIGATION, 2015, 95 : 372A - 372A
  • [45] MYD88L265P mutated IgA lymphoplasmacytic lymphoma
    Urquieta Lam, Marcela
    Moreno Aguirre, Alejandra
    Perena Gonzalez, Ainara
    Gonzalez de Villambrosia, Sonia
    Nunez Cespedes, Javier
    Garcia Reyero, Julia
    Montes Moreno, Santiago
    HISTOPATHOLOGY, 2019, 75 (04) : 608 - 612
  • [46] Detection of MYD88 L265P mutations in formalin-fixed and decalcified BM biopsies from patients with lymphoplasmacytic lymphoma
    Belen Capaldi, Ianina
    May, Annette M.
    Schmitt-Graeff, Annette
    Follo, Marie
    Aumann, Konrad
    Kayser, Gian
    Carlos Perazzo, Juan
    Werner, Martin
    Fisch, Paul
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2014, 97 (01) : 57 - 65
  • [47] MYD88 L265P Mutation: A Valid Tool for Differential Diagnosis of Indolent Lymphoma With Overlapping Clinicopathologic Features?
    Preukschas, Michael
    Lebherz, Marina
    Hallas, Cora
    Tiemann, Markus
    MODERN PATHOLOGY, 2015, 28 : 372A - 372A
  • [48] CLINICAL IMPLICATIONS OF MYD88 L265P MUTATION IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA
    Sidorova, A.
    Zvonkov, E.
    Sudarikov, A.
    Severina, N.
    Gabeeva, N.
    Kovrigina, A.
    Troitskaya, V.
    Savchenko, V.
    HAEMATOLOGICA, 2016, 101 : 816 - 816
  • [49] High Frequency of MYD88 L265P Mutation in Ocular Adnexal Marginal Zone Lymphomas and Its Clinical Correlates
    Behdad, A.
    Zhou, X. Y.
    Dittman, D.
    Qi, C.
    Gao, J.
    Betz, B.
    Chen, Y.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2017, 19 (06): : 969 - 970
  • [50] MYD88 L265P Somatic Mutation in Waldenstrom's Macroglobulinemia
    Treon, Steven P.
    Xu, Lian
    Yang, Guang
    Zhou, Yangsheng
    Liu, Xia
    Cao, Yang
    Sheehy, Patricia
    Manning, Robert J.
    Patterson, Christopher J.
    Tripsas, Christina
    Arcaini, Luca
    Pinkus, Geraldine S.
    Rodig, Scott J.
    Sohani, Aliyah R.
    Harris, Nancy Lee
    Laramie, Jason M.
    Skifter, Donald A.
    Lincoln, Stephen E.
    Hunter, Zachary R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (09): : 826 - 833
12345